as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹630.9
Change
+10.1 (1.63%)
Open
₹624.5
Prev. Close
₹620.8
Day High
₹634.0
Day Low
₹615.15
Volume Analysis
Traded
46,193
Delivered
25,123
Delivery %
54.39%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (1)
- •Low return on equity (-0.05%)
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹657.06 | ₹645.53 | ₹638.21 | ₹626.68 | ₹619.36 | ₹607.83 | ₹600.51 |
| Fibonacci | ₹645.53 | ₹638.33 | ₹633.88 | ₹626.68 | ₹619.48 | ₹615.03 | ₹607.83 |
| Camarilla | ₹636.08 | ₹634.36 | ₹632.63 | ₹626.68 | ₹629.17 | ₹627.44 | ₹625.72 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+25.94%
1 Week
+0.22%
1 Month
-10.74%
3 Months
+2.68%
6 Months
+6.7%
1 Year
+12.74%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
1.24%
Net margin 1.47% × asset turnover 0.58x × equity multiplier 1.45x
Company Overview
Sector
Chemicals
Market Cap
₹4,605 Cr
P/E (TTM)
69.4
ROE
-0.05%
Book Value
₹707.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Gujarat Alkalies & Chem lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 55/100. The strongest factor is Financial Strength (100/100), while Growth (31/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (-0.05%). FII holding has been rising.
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Stock is trading at 0.89 times its book value
- −Company has a low return on equity of -1.76% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Intimation of Schedule of Analyst / Institutional Investor Meeting with HSBC Securities and Capital Markets (India) Pvt. Ltd. For more details kindly refer attached file.
Newspaper clippings of Notice of 53rd Annual General Meeting E-voting information and Record Date.
Filed BRSR for FY 2025-26 as part of Gujarat Alkalies’ 53rd Annual Report.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 913 | 971 | 921 | 1,002 | 977 | 991 | 1,029 | 1,075 | 1,105 | 1,083 | 1,044 | 1,125 | 1,245 |
| Expenses + | 882 | 955 | 941 | 998 | 923 | 945 | 951 | 974 | 1,010 | 1,009 | 948 | 1,015 | 1,023 |
| Operating Profit | 31 | 16 | -20 | 4 | 54 | 46 | 78 | 101 | 95 | 74 | 96 | 110 | 222 |
| OPM % | 3.4% | 1.7% | -2.2% | 0.4% | 6.0% | 4.7% | 8.0% | 9.0% | 9.0% | 7.0% | 9.0% | 10.0% | 18.0% |
| Other Income + | 12 | 71 | 5 | 3 | 3 | 49 | 15 | 24 | 8 | 59 | 30 | 25 | 9 |
| Interest | 10 | 11 | 11 | 12 | 11 | 11 | 10 | 18 | 14 | 16 | 18 | 15 | 16 |
| Depreciation | 89 | 95 | 96 | 97 | 97 | 100 | 98 | 97 | 102 | 104 | 104 | 104 | 103 |
| Profit before tax | -57 | -18 | -123 | -102 | -50 | -16 | -15 | 10 | -12 | 14 | 4 | 15 | 112 |
| Tax % | 0.0% | 0.0% | -6.0% | -55.0% | -11.0% | 15.0% | -27.0% | 13.0% | 15.0% | -21.0% | 621.0% | 3.0% | 51.0% |
| Net Profit + | -57 | -18 | -115 | -46 | -45 | -18 | -11 | 9 | -14 | 16 | -20 | 15 | 55 |
| EPS in Rs | -8 | -3 | -16 | -6 | -6 | -2 | -2 | 1 | -2 | 2 | -3 | 2 | 7 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,358 | 4,498 |
| Expenses + | 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,793 | 3,975 | 3,996 |
| Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 279 | 383 | 501 |
| OPM % | 17.0% | 22.0% | 32.0% | 35.0% | 21.0% | 15.0% | 26.0% | 21.0% | 0.8% | 7.0% | 9.0% | 11.0% |
| Other Income + | 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 92 | 115 | 124 |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 63 | 66 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 414 | 416 |
| Profit before tax | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -71 | 21 | 144 |
| Tax % | 16.0% | 19.0% | 29.0% | 32.0% | 32.0% | 29.0% | 32.0% | 41.0% | -21.0% | -9.0% | 112.0% | — |
| Net Profit + | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | -2 | 66 |
| EPS in Rs | 30 | 42 | 73 | 94 | 45 | 23 | 76 | 56 | -32 | -9 | 0 | 9 |
| Dividend Payout % | 15.0% | 12.0% | 9.0% | 9.0% | 18.0% | 35.0% | 13.0% | 42.0% | -43.0% | -178.0% | -5,394.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 5,596 | 5,117 |
| Borrowings + | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | 575 |
| Other Liabilities + | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | 1,766 |
| Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 7,533 |
| Fixed Assets + | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | 4,343 |
| CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 | 122 |
| Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 1,976 | 1,633 |
| Other Assets + | 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | 1,434 |
| Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 7,533 |
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 201 | 502 | 514 | 838 | 630 | 421 | 735 | 960 | 67 | 381 | 406 |
| Cash from Investing Activity + | -352 | -467 | -395 | -581 | -634 | -334 | -804 | -662 | -90 | -264 | -225 |
| Cash from Financing Activity + | 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 | -150 |
| Net Cash Flow | -67 | 49 | 3 | 122 | -150 | 313 | -58 | 158 | -301 | -28 | 31 |
| CFO/OP | 75 | 132 | 83 | 98 | 121 | 133 | 106 | 121 | 353 | 112 | 100 |
| Free Cash Flow | -80 | 63 | 230 | 451 | 56 | -370 | -173 | 277 | -164 | 59 | 148 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 49.88% | 49.49% | 48.48% | 48.34% | 48.01% | 47.79% | 47.84% | 48.36% | 48.16% | 48.01% | 48.04% | 46.44% |
| Promoters | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 46.28% | 47.28% | 47.28% |
| FII | 1.88% | 2.07% | 2.1% | 1.92% | 1.94% | 1.79% | 1.71% | 1.02% | 1.02% | 0.96% | 0.94% | 3.26% |
| DII | 1.96% | 2.17% | 3.13% | 3.46% | 3.76% | 4.14% | 4.17% | 4.35% | 4.52% | 4.75% | 3.72% | 3.02% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Gujarat Alkalies & Chem (this stock) | 4,605 | 69.4 | 0.89 | -0.05% |
| Vishnu Chemicals Limited | 4,696 | 31.4 | 4.39 | 14.3% |
| Epigral Limited | 4,718 | 17.4 | 2.12 | 16.0% |
| Prasol Chemicals Limited | 4,474 | 103.0 | — | 12.6% |
| Dhanuka Agritech Ltd | 4,385 | 15.0 | 3.16 | 22.0% |
| Foseco India Ltd | 4,868 | 46.7 | 4.7 | 12.6% |
| Tatva Chin Pharm Chem Ltd | 4,195 | 80.1 | 5.37 | 5.54% |
Which Mutual Funds Hold Gujarat Alkalies & Chem?
Frequently Asked Questions about Gujarat Alkalies & Chem
Gujarat Alkalies & Chem (GUJALKALI) closed at ₹630.9 on NSE on 25 September 2026, up 10.1 (1.63%) from the previous close.
Gujarat Alkalies & Chem trades on the NSE (National Stock Exchange of India) under the symbol GUJALKALI.
Gujarat Alkalies & Chem has a trailing twelve-month P/E (price-to-earnings) ratio of 69.4.
Gujarat Alkalies & Chem has a dividend yield of 2.82%.
Gujarat Alkalies & Chem's 52-week high is ₹815.0 and its 52-week low is ₹409.0.
Gujarat Alkalies & Chem has a market capitalisation of ₹4,605 crore.
Gujarat Alkalies & Chem has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Gujarat Alkalies & Chem?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.